Nasal immunization with RSV F and G protein fragments conjugated to an M cell-targeting ligand induces an enhanced immune response and protection against RSV infection-Reference-Cited by-同舟云学术

Nasal immunization with RSV F and G protein fragments conjugated to an M cell-targeting ligand induces an enhanced immune response and protection against RSV infection

Published:2018-11 Issue: Volume:159 Page:95-103
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Khan Inam Ullah,Huang Jiansheng,Li Xue,Xie Jun,Zhu Naishuo

Funder

Major National Projects for Infectious Diseases Research

New Drug Research & Development

National Natural Science Foundation of China

Science and Technology Commission of Shanghai

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference55 articles.

1. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice;Bian;Antivir. Res.,2014

2. Enhancing immune responses by targeting antigen to DC;Caminschi;Eur. J. Immunol.,2009

3. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease;Castilow;Immunol. Res.,2007

4. The CD4 T cell response to respiratory syncytial virus infection;Christiaansen;Immunol. Res.,2014

5. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia–RSV recombinants or RSV;Connors;Vaccine,1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiral Intranasal Nanovaccines as Antivirals for Respiratory Syncytial Virus;Advanced Materials;2024-09-02

2. Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine;npj Vaccines;2024-06-26

3. Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice;Biochemical and Biophysical Research Communications;2022-08

4. Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection;Scientific Reports;2021-09-20

5. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins;Viruses;2021-04-06